Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens.
Nahta
R
R
Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322.
Shabaya
S
S
Ozbay
T
T
Rowe
D L
DL